| Trial Identifier: | ACH471-101 |
| Sponsor: | Alexion Pharmaceuticals, Inc. |
| Collaborator: |
Achillion, a wholly owned subsidiary of Alexion
|
| Start Date: | May 2018 |
| Primary Completion Date: | September 2019 |
| Study Completion Date: | January 2023 |
| Condition: | Heart, Blood & Circulatory - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version | |
| Italian (Italy) Translation | |
| English (UK) Translation |
| Country | Location |
|---|---|
| Italy | Florence, Italy |
| Italy | Naples, Italy |
| United Kingdom | London, United Kingdom |
| United States, Maryland | Baltimore, Maryland, United States, 21287 |
| United States, Ohio | Cleveland, Ohio, United States, 44195 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company